Pfizer and BioNTech seek FDA authorization for updated Covid-19 booster

Home » Top Stories » Pfizer and BioNTech seek FDA authorization for updated Covid-19 booster

Pfizer and BioNTech have submitted their application to the US Food and Drug Administration for emergency use authorization of their bivalent Covid-19 vaccine for use in people age 12 and older, the companies said in a statement on Monday.

Categories:

Related Posts

FDA clears the way for additional bivalent boosters for certain vulnerable individuals
The U.S. Food and Drug Administration amended the terms of its emergency use authorizations for
Repeated gunshots fired on live TV as ex-lawmaker shot by assassins
Atiq Ahmed, a former lawmaker in India's parliament, convicted of kidnapping, was shot dead along
US warns Russia not to touch American nuclear technology at Ukrainian nuclear plant
The US has sensitive nuclear technology at a nuclear power plant inside Ukraine and is